Lumosa Therapeutics Co (ROCO:6535) Cash From Discontinued Investing Activities : NT$0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Lumosa Therapeutics Co Cash From Discontinued Investing Activities?

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Lumosa Therapeutics Co's cash from discontinued investing activities for the three months ended in Sep. 2024 was NT$0.00 Mil. It means Lumosa Therapeutics Co received NT$0.00 Mil from discontinued investing activities. Lumosa Therapeutics Co's cash from discontinued investing activities for the trailing twelve months (TTM) ended in Sep. 2024 was NT$0.00 Mil.

Lumosa Therapeutics Co Cash From Discontinued Investing Activities Historical Data

The historical data trend for Lumosa Therapeutics Co's Cash From Discontinued Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumosa Therapeutics Co Cash From Discontinued Investing Activities Chart

Lumosa Therapeutics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash From Discontinued Investing Activities

Get a 7-Day Free Trial

Lumosa Therapeutics Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Cash From Discontinued Investing Activities	Get a 7-Day Free Trial															-	-	-	-	-

Lumosa Therapeutics Co Cash From Discontinued Investing Activities Calculation

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Cash From Discontinued Investing Activities for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.00 Mil.

Lumosa Therapeutics Co Cash From Discontinued Investing Activities Related Terms

Thank you for viewing the detailed overview of Lumosa Therapeutics Co's Cash From Discontinued Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Lumosa Therapeutics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lumosa Therapeutics Co Ltd (ROCO:6535) » Definitions » Cash From Discontinued Investing Activities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Yuanyuan Street, 4th Floor, No. 3-2, Nangang District, Taipei, TWN, 11503

Website

https://www.lumosa.com.tw

Lumosa Therapeutics Co Ltd develops new drugs. The company is engaged in the development of drugs for unmet medical needs in the fields of CNS, oncology, and inflammatory diseases. Geographically, it derives a majority of its revenue from Asia and also has a presence in Taiwan, Europe, and America. Its product pipeline is Neuroscience which includes LT 1001 for Postoperative Pain, LT 3001 for Acute Ischemic Stroke, LT 5001 for Uremic Pruritus, LT 6001 for Neurological disorder, and Oncology including LT 2003 for Solid Tumor. It generates revenue from sales of goods.

Lumosa Therapeutics Co Headlines

No Headlines